SURMODICS INC (SRDX)

Overview Price 14.32 Price Change Today 0.00 (0.00%) P&P rating Zacks Rank 3 - HOLD Open Price $0.00 Previous Close $14.32 Daily Range $0.00 - $0.00 52-Week Range $8.73 - $15.50 Volume 0 SurModics, Inc. is a leading provider of surface modification technologies in the areas of biocompatibility, site specific drug delivery, biological cell encapsulation, and medical diagnostics. SurModics partners with the world's foremost medical device, pharmaceutical and life science companies to bring innovation together for better patient outcomes. Recent collaborative efforts include the implementation of SurModics' Bravo drug delivery polymer matrix as a key component of the first-to-market drug-eluting coronary stent. SurModics is also active in the ophthalmology market with a sustained drug delivery system that is currently in human trials for treatment of retinal disease. A significant portion of SurModics' revenue is generated by royalties earned from the sale of our customers' commercial products. Other Resources for SRDX Detailed Quote Earnings Estimates Company Report Interactive Chart Commentary Zacks Blog: SurModics Reports In-Line EPS February 7, 2012 Zacks Blog: SurModics Cut to Neutral January 16, 2012 Zacks Blog: Zacks #1 Rank Additions for Thursday December 29, 2011 Zacks Blog: SurModics Upped to Outperform November 14, 2011 Zacks Blog: Zacks Releases Four Powerful ''Buy'' Stocks: SurModics, Norfolk Southern, MarketAxess Holdings and Standard Motor Products November 10, 2011 SurModics, Inc. is a leading provider of surface modification technologies in the areas of biocompatibility, site specific drug delivery, biological cell encapsulation, and medical diagnostics. SurModics partners with the world's foremost medical device, pharmaceutical and life science companies to bring innovation together for better patient outcomes. Recent collaborative efforts include the implementation of SurModics' Bravo drug delivery polymer matrix as a key component of the first-to-market drug-eluting coronary stent. SurModics is also active in the ophthalmology market with a sustained drug delivery system that is currently in human trials for treatment of retinal disease. A significant portion of SurModics' revenue is generated by royalties earned from the sale of our customers' commercial products.   Brokerage Analyst Recommendations 4 Brokerage Firms Covering SRDX   Strong Buy 2 Buy 0 Hold 2 Sell 0 Strong Sell 0 Average Broker Recommendation (ABR): 2   SRDX Ratings: BUY  SELL  HOLD SRDX Consensus Forecasts

Rate this Stock! You haven't rated this stock yet! Ticker Call Buy Sell Analysis Time Frame Week or Less Week to a Month One to Three Months Three to Six Months Six Months to a Year One to Three Years Three Plus Years What The Community Thinks Total Players 5 Buy 1 Sell   Top Buy Analysis No Buy Analysis. Be the First. More Recent Analysis Top Sell Analysis No Sell Analysis. Be the First. More Recent Analysis

Blog Posts

User	User Score	Date	Title	Comments	Last Comment
Zacks_Analysts	0.00	02/07/12	SurModics Reports In-Line EPS - Analyst Blog	0
Zacks_Analysts	0.00	01/16/12	SurModics Cut to Neutral - Analyst Blog	0
Zacks_Analysts	0.00	11/14/11	SurModics Upped to Outperform - Analyst Blog	0
Zacks_Analysts	0.00	11/09/11	SurModics Beats Estimates - Analyst Blog	0
Zacks_Analysts	0.00	09/27/11	New Product from SurModics - Analyst Blog	0
Zacks_Analysts	0.00	08/26/11	SurModics Retains the Neutral Tag - Analyst Blog	0
Zacks_Analysts	0.00	08/24/11	SurModics to Trim Workforce - Analyst Blog	0
Zacks_Analysts	0.00	08/08/11	SurModics Tops, Lifts View - Analyst Blog	0
Zacks_Analysts	0.00	07/07/11	SurModics Cut to Neutral - Analyst Blog	0
Zacks_Analysts	0.00	06/17/11	Setback for SurModics - Analyst Blog	0

Pages: [ 1 ]  2   3  >>

Commentary

BUY: SURMODICS INC. (SRDX) Start Price: $14.78 Points: -11.56 Created: 12/22/2011 Comments: 0 | Comment ATYChan Recs:

BUY: SURMODICS INC. (SRDX) Start Price: $33.85 Points: -50.00 Created: 01/01/2008 Comments: 0 | Comment car Recs:

SELL: SURMODICS INC. (SRDX) Start Price: $33.74 Points: +49.86 Created: 01/01/2008 Comments: 0 | Comment Boriavi Recs:

BUY: SURMODICS INC. (SRDX) Start Price: $47.08 Points: -61.78 Created: 01/01/2008 Comments: 0 | Comment mrmem Recs:

BUY: SURMODICS INC. (SRDX) Start Price: $31.99 Points: -47.55 Created: 01/01/2008 Comments: 0 | Comment bullmove Recs:

BUY: SURMODICS INC. (SRDX) Start Price: $48.59 Points: -62.72 Created: 01/01/2008 Comments: 0 | Comment traderetard Recs:

Picks

Username	P&P Score	Call	Time Frame	Start Date	Start Price	Today (change)	Stock Gain	S&P Gain	Points	Analysis
ATYChan	99.54	BUY	Week to a Month	12/22/2011	$14.78	$14.20 (+1.07%)	-3.92%	+7.63%	-11.56
car	45.73	BUY	Six Months to a Year	01/01/2008	$33.85	$14.20 (+1.07%)	-58.05%	-8.05%	-50.00
Boriavi	83.08	SELL	Six Months to a Year	01/01/2008	$33.74	$14.20 (+1.07%)	-57.91%	-8.05%	+49.86
mrmem	28.46	BUY	Six Months to a Year	01/01/2008	$47.08	$14.20 (+1.07%)	-69.84%	-8.05%	-61.78
bullmove	73.66	BUY	Six Months to a Year	01/01/2008	$31.99	$14.20 (+1.07%)	-55.61%	-8.05%	-47.55
traderetard	88.74	BUY	Six Months to a Year	01/01/2008	$48.59	$14.20 (+1.07%)	-70.78%	-8.05%	-62.72